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1. Introduction 
Pancreatic cancer (PCa) as one of the most aggressive malignancies of mankind has an 
unparallelled propensity to invade intrapancreatic nerves. This “neural invasion” is 
therefore one of the most frequent routes of spread in PCa in addition to lymphatic and 
vascular paths. The major clinical relevance of neural invasion (NI) has triggered intense 
research efforts to understand its pathomechanims, and the findings derived from all these 
studies show how multi-faceted this peculiar route of cancer invasion in PCa is. This chapter 
is devoted to a thorough description of the characteristics, the pathomechanism and the 
clinical impact of NI in PCa, with the discussion of the most important pathways which may 
be future targets for therapeutic intervention. 
2. What is “neural invasion” in pancreatic cancer? 
NI is a relatively new and more comprehensive term for the traditionally used description 
“perineural invasion”. In several malignancies, e.g. in the prostate, head and neck, but also 
several gastrointestinal malignancies, cancer cells are commonly encountered around nerves 
(Liebig et al., 2009). The frequent presence of cancer cells along the perineurium, the protective 
sheet around neural fascicles, has hence made pathologists adopt the term “perineural 
invasion”. Classically, cancer cells which penetrate through the epineurium come to lie 
between the epineurium and the underlying perineurium and “push” on the nerve fascicles 
within the constrained intraneural area. The earliest report on perineural invasion stems from 
Cruveilheir in 1835 where he noticed that cancer cells can actually extend along the invaded 
nerves (Demir et al., 2010). Interestingly, although pathologists frequently observed perineural 
invasion in several types of tumors, its role except for serving as an additional path of cancer 
spread has not been genuinely investigated and understood until 1990s. In his pioneering 
article on the ultrastructural features of perineural invasion in PCa, Dale Bockman from 
Augusta, Georgia, USA performed an electron microscopic analysis of invaded nerves in PCa 
(Bockman et al., 1994). There, he noted that, in contrast with the traditional assumption, PCa 
cells penetrate through the perineurium and become intimately associated with the interior of 
nerve fascicles, i.e. axons and Schwann cells (Bockman et al., 1994). These observations made 
by Bockman during mid-1990s laid the foundation for our understanding and the subsequent 
research on NI in PCa into the present time. 
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It should be noted that NI is often used to denote invasion of intrapancreatic nerves 
(Liu&Lu, 2002). However, it is at the same time a more comprehensive term for intra- as 
well as extrapancreatic nerve invasion (Bockman et al., 1994; Takahashi et al., 1997; 
Takahashi et al., 2001; Mitsunaga et al., 2007). In contrast with their European counterparts, 
several studies from the Far East were devoted to the study of extrapancreatic nerve 
invasion through collection of specimens from retro- and peripancreatic nerves during 
autopsy (Nakao et al., 1996; Takahashi et al., 1997; Hirai et al., 2002; Liu&Lu, 2002; 
Mitsunaga et al., 2007). In those studies, “extrapancreatic nerve invasion” is often used 
synonymously with NI (Nakao et al., 1996; Takahashi et al., 1997; Hirai et al., 2002; Liu&Lu, 
2002; Mitsunaga et al., 2007). 
3. What are the specific histological characteristics of NI in PCa? 
A review of scientific literature on NI in PCa reveals that NI has mostly been perceived as 
the presence of PCa on and along the perineurium (Kayahara et al., 2007; Liebig et al., 2009). 
Recent studies, however, revealed that PCa cells are readily encountered in the endoneural 
area, i.e. between nerve fascicles, as originally observed by Bockman (Ceyhan et al., 2009). 
Consequently, subsequent studies applied a scoring system to describe the degree of 
penetration of PCa cells into intrapancreatic nerves, classifying NI into “no invasion” (score 
of 0/zero), “perineural invasion” (score of I/one) and “endoneural invasion” (score of 
II/two) (Ceyhan et al., 2006; Ceyhan et al., 2009; Ceyhan et al., 2011). Importantly, the 
presence of PCa cells in the interior of nerves should not necessarily be perceived as the 
invasion of the “endoneurium” which is the connective tissue within nerve fascicles of a 
nerve. Similarly, invasion around nerves does not directly imply invasion of the 
“perineurium” as the connective tissue layer encircling nerve fascicles. Rather, “endo-“ and 
“perineural” stand for “between” or “around” nerve fascicles (Figure 1) (Ceyhan et al., 2009; 
Ceyhan et al., 2011). 
Careful examination of PCa tissue specimens also reveals that the presence of NI is not 
independent of the localization of the nerves within the pancreatic tissue. Particularly, we 
could demonstrate that NI in ductal adenocarcinoma of the pancreas is detected more 
frequently in areas with severe desmoplasia (Ceyhan et al., 2009). The reasons for this 
association between desmoplasia and NI are so far not known. However, it is assumed that 
the extracellular matrix is a rich source of growth factors which may be trophic upon nerves 
(Zhu et al., 1999; Demir et al., 2010). Still, NI should not be assumed to be limited to 
desmoplastic areas. In a histopathological study on the normal pancreatic regions of PCa 
patients who underwent pancreatic resection, NI was also encountered in normal pancreatic 
areas which are distant from the actual tumor (Takahashi et al., 1997). In the original study, 
this type of NI termed “nex” was found in more than 50% of resected pancreatic specimens 
and correlated to the grade of intrapancreatic neural invasion or the presence of 
extrapancreatic neural plexus invasion (Takahashi et al., 1997). Moreover, its presence was 
also found to correlate to worse survival after removal of the tumor (Takahashi et al., 1997). 
Therefore, the presence of NI in the supposedly normal regions of the pancreas implies that 
NI is a rapidly progressive process where PCa cells grow very early along intrapancreatic 
nerves. 
The different histological appearances of NI in PCa have also been employed to understand 
its pathomechanism and spread pattern. In a study by Kayahara et al. (Kayahara et al., 
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2007), the investigators analyzed consecutive sections of surgically resected PCa specimens 
in order to elucidate the main patterns of cancer cell growth along nerves: (1) direct invasion 
of the nerves, (2) continuous tumor cells growth in the perineural space, (3) branching of the 
growing tumor mass along neural branches, (4) formation of a foremost growth cone of 
tumor cells, and (5) direct invasion of contiguous lymph nodes (Kayahara et al., 2007). 
Hence, the authors could provide an anatomical mechanism for the manifestation of NI and 
particularly extrapancreatic neural plexus invasion. Importantly, their study proved the 
continuous growth of PCa cells along intrapancreatic nerves towards the extrapancreatic 
neural plexus (Kayahara et al., 2007). 
4. Why is neural invasion so deciding in the course of PCa? 
There are several factors which make NI a crucial aspect of PCa and an attractive field of 
research. First, NI has an utmost high prevalence in PCa, varying between 88% to 100% 
(Takahashi et al., 2001; Liu&Lu, 2002). Interestingly, according to a study by Kayahara et al., 
NI in PCa is significantly more common than in cancers which originate from direct 
anatomical neighbours of the pancreas, e.g. cancers of the distal bile duct or carcinoma of 
the papilla of Vater (Kayahara et al., 1991; Kayahara et al., 1993; Kayahara et al., 1994; 
Kayahara et al., 1995; Kayahara et al., 1996). Unfortunately, intrapancreatic NI is nearly 
always accompanied by invasion to the extrapancreatic neural plexus: In their series, Nakao 
et al detected intrapancreatic NI in 116 out of 129 (90%) patients, of whom 80 (69%) showed 
extrapancreatic nerve plexus involvement (Nakao et al., 1996). Based on these findings, it 
seems that clinicians should assume the presence of NI in every patient with PCa even if the 
pathology report does not include a statement regarding this histopathological feature. 
In the face of such a high prevalence, NI is at the same time one of the foremost reasons for 
local tumor recurrence after curative tumor resection (Kayahara et al., 1991; Nagakawa et al., 
1991; Kayahara et al., 1995; Kayahara et al., 1996; Nagakawa et al., 1996; Ozaki et al., 1999). 
In a study by Kayahara et al., the investigators analyzed the mode of recurrence in 30 
patients who had originally undergone macroscopically curative resection (Kayahara et al., 
1993; Liu&Lu, 2002). They showed that the rate of local retroperitoneal recurrence, i.e. the 
prevalence of extrapancreatic NI was 80%, of hepatic metastasis 66%, of peritoneal 
dissemination 53%, and of lymph node recurrence 47%, an observation which was 
confirmed by further antemortem studies (Kayahara et al., 1993; Kayahara et al., 1995; 
Liu&Lu, 2002). Among the several parts of the extrapancreatic neural plexus which 
demonstrate local tumor recurrence, pancreatic head plexus and splenic plexus are the most 
common sites of tumor recurrence (Liu&Lu, 2002). Based on the frequency of NI towards 
retropancreatic neural plexus, several surgeons advocated routine extended resections 
(including celiac plexus) or at least more aggressive surgery in the surgical treatment of PCa 
(Hiraoka et al., 1986; Nagakawa et al., 1991; Nagakawa et al., 1996; Imamura et al., 1999). 
However, subsequent clinical studies confirmed that, while extended resection - even in 
combination with radiotherapy- can contribute to local tumor control, there is no survival 
benefit for patients due to the early spread pattern of PCa (Bachmann et al., 2006; Takamori 
et al., 2008; Yokoyama&Nagino, 2011). However, these studies mostly concentrated on more 
extensive lymphadenectomy rather than plexus resection as the actual measure to reduce 
NI. In further newer studies (Hirano et al., ; Sperti et al., ; Kondo et al., 2001; Hirano et al., 
2007; Chakravarty et al., 2011), the feasibility and safety of an en bloc resection including 
celiac artery, plexus and ganglia was demonstrated, but the actual survival beneift from this   
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Fig. 1. Severity of neural invasion (NI) in pancreatic cancer (PCa). Examination of 
intrapancreatic nerves with NI reveals that PCa cells demonstrate varying degrees of 
interaction with the nerves. In many cases, PCa cells surround intrapancreatic nerves 
without breaching the epineural barrier (A, also termed epineural association). On the other 
hand, several nerves demonstrate a lack of the epineural barrier where pancreatic cancer 
cells surround the fascicles along their perineurium (B, perineural invasion). In most severe 
cases, PCa cells are encountered between nerve fascicles, along their endoneurium (C, 
endoneural invasion). There is a significant association between the severity of NI and the 
degree of pain sensation among PCa patients (please refer to the main text for the respective 
references). All images at 200x magnification. 
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radical operation remains to be demonstrated. Importantly, a common denominator of 
these studies on “en bloc” resection of retropancreatic neural plexus is the pronounced 
pain relief as a result of the resection of celiac plexus(Kondo et al., 2001; Hirano et al., 
2007). This deciding association between extrapancreatic neural plexus and pain sensation 
builds up the link to the concept of “pancreatic neuropathy” in PCa which encompasses 
NI and several other neural alterations in PCa(Ceyhan et al., 2009), as explained in the 
following section. 
5. Neural invasion as part of “pancreatic neuropathy” in PCa 
The pancreas is one of the most densely innervated visceral organs(Bradley&Bem, 2003). 
The extrinsic component of its innervation is composed of nerve fibers running within the 
vagal and splanchnic nerves which originate from vagal nuclei or DRGs, respectively. Like 
the intestine, it also has an intrinsic innervation which is represented by intrapancreatic 
neurons. Importantly, enteric and intrapancreatic neurons are embryologically closely 
related: intrapancreatic neurons develop from a subgroup of neural crest-derived enteric 
nervous system (ENS) precursors and thus belong to the ENS (Kirchgessner&Gershon, 1990; 
Kirchgessner&Gershon, 1991). Moreover, there exists a direct innervation of the  
pancreas from the duodenum termed “entero-pancreatic innervations”, as evidenced by the 
entrance of nerve fibers directly from the duodenal ENS into intrapancreatic ganglia 
(Kirchgessner&Gershon, 1990; Kirchgessner&Gershon, 1991). 
In the currently most comprehensive systematic analysis of NI in PCa, our group aimed at 
the study of nerve morphology in 546 patients with different pancreatic tumors, including 
ductal adenocarcinoma, neuroendocrine tumors, intraductal papillary mucinous neoplasms 
(IPMN), serous and mucinous cystadenoma and other neoplasms of the pancreas (Ceyhan et 
al., 2009). In the mentioned study, we could demonstrate that ductal adenocarcinoma of the 
pancreas exhibits the highest degree of NI in comparison to all other pancreatic tumors 
(Ceyhan et al., 2009). Interestingly, ductal adenocarcinoma (PCa) also harbored an 
unparalleled degree of nerve alterations among all these tumors (Ceyhan et al., 2009). In 
particular, PCa was characterized by a prominently increased neural density, a pronounced 
neural hypertrophy and neural inflammatory cell infiltration (“pancreatic neuritis”) 
(Ceyhan et al., 2006; Ceyhan et al., 2009). Moreover, we could also detect a key link between 
the severity of NI in PCa and the extent of intrapancreatic neuroplastic alterations: The more 
nerves and neural hypertrophy were present, the higher was the extent/severity of NI in 
PCa (Ceyhan et al., 2009).  
This association between pancreatic neuroplasticity and NI gained a further dimension in a 
subsequent study where the pancreatic “innervation quality” in PCa was studied and 
compared to normal human pancreas (NP) (Ceyhan et al., 2009). Interestingly, not only had 
nerves in PCa tissue fewer sympathetic nerve fibers than in NP, but nerves with NI had at 
the same time reduced amounts of both sympathetic and cholinergic nerve fibers (Ceyhan et 
al., 2009). This “neural remodeling” in PCa implies that PCa cells may not be arbitrarily 
invading intrapancreatic nerves but also aiming at specific fiber qualities for so far unknown 
reasons. Overall, these neural alterations which seem to be specific for PCa, i.e. pancreatic 
neuroplasticity, neural remodeling and the high degree of NI, are the three hallmarks of so-
called “pancreatic neuropathy” in PCa (Ceyhan et al., 2009). 
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While the mechanisms of these neuroplastic alterations are not completely understood, there 
is increasing evidence that these neuropathic alterations in PCa can in part be attributed to 
the neurotrophic character of the tumor microenvironment in PCa (Demir et al., 2010). In a 
novel in vitro neuroplasticity assay, we could demonstrate that tissue extracts of PCa, PCa 
cell supernatants and supernatants of human pancreatic stellate cells as main generators of 
desmoplasia can all induce axonal sprouting, increased neurite density and perikaryonal 
hypertrophy of neurons isolated from dorsal root ganglia or myenteric plecus under in vitro 
conditions (Demir et al., 2010). In a very recent study, Li et al. added a novel dimension to 
our understanding of neural alterations in PCa: In accordance with their former hypothesis 
(Li&Ma, 2008), patients with hyperglycemia demonstrate more pronounced neural 
hypertrophy and increased neural density than normoglycemic patients (Li et al., 2011). 
Hence, it is to be expected that research on pancreatic neuroplasticity and especially NI in 
PCa may take a direction towards increased investigation of the impact of impaired glucose 
metabolism upon pancreatic neuropathy in PCa. 
6. The role of neural invasion in the pain due to PCa 
Decreased survival and local tumor recurrence are undoubtedly among the leading factors 
which make NI into a highly relevant clinical subject. However, within the true clinical 
impact of NI, its role in pain sensation occupies a special place. It has long been accepted that 
the extension of PCa along the intrapancreatic nerves towards extrapancreatic neural plexus 
may be a causal factor in the generation of pain in advanced Pca (Kayahara et al., 1991; 
Nakao et al., 1996; Kayahara et al., 2007). Bockman also postulated a significant role for NI 
in pain generation in PCa(Bockman et al., 1994), but the actual pioneering study in this 
context came from Zhu et al. who for the first time demonstrated the correlation between 
the intrapancreatic expression of the nerve growth factor (NGF)(Zhu et al., 1999), the 
frequency of perineural invasion and the degree of pain sensation in PCa patients, an 
observation which was later also discovered for the expression of NGF receptor TrkA 
(Zhang et al., 2005; Dang et al., 2006). Owing to this study and its successors, it became 
increasingly clear that the extent of NI in the pancreas affects pain sensation, where nerve-
derived molecules like NGF play a key role in both pain sensation and potentially in the 
attraction of PCa cell to nerves (Demir et al., 2010). The resulting interest in such nerve-
derived mediators, especially in neurotrophic factors, have inaugurated the era of research 
on the molecular biological mechanisms of NI which last until the present time (Demir et al., 
2010). Moreover, the identified cross-link between NI, pancreatic neuroplastic alterations 
and pain sensation by PCa patients revealed the potential involvement of “neuropathic” 
pain mechanisms in PCa (Ceyhan et al., 2009; Demir et al., 2010). Hence, researchers and 
clinicians have recently and increasingly understood that damage to nerves within the 
pancreas may be the actual pain-triggering mechanism in PCa  (Ceyhan et al., 2009; Demir et 
al., 2010). 
One can assume that the blockade of pain transmission via the damaged nerves from the 
pancreas may be of major benefit to treat pain due to PCa. As the celiac plexus contains a 
large portion of the afferent nerve fibers from the pancreas, several studies have tested the 
efficieny of celiac plexus blockade/neurolysis in the treatment of pain due to PCa. In all 
these studies, patients had significant pain relief (Wong et al., 2004; Stefaniak et al., 2005; 
Yan&Myers, 2007) following this intervention. While the efficiency of this “denervation” 
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technique does not necessarily prove the neuropathic character of pain in PCa, it underlines 
the deciding contribution of nerves and the transmitted signals in the generation of the pain 
syndrome in PCa (Ceyhan et al., 2008) Considering the neuropathic character of pain in PCa, 
one can assume that neuropathic analgesics may be of benefit to treat PCa-associated pain. 
As of today, the impact of neuropathic analgesic regimens to treat of patients with advanced 
PCa has not yet been systematically investigated.  
7. Why are pancreatic cancer cells attracted to nerves? Molecular 
mechanisms of neural invasion in PCa 
7.1 In vitro models 
Researchers and clinicians have long puzzled about why PCa cells are frequently 
encountered around intrapancreatic nerves. Early reports had claimed that PCa cells enter 
nerves through the perineurium at its weakest points, i.e. along neural lymph vessels(di 
Mola&di Sebastiano, 2008), which, however, could not be confirmed in later studies. In later 
studies, investigators suggested that PCa cells grow along the path of least resistance after 
entering nerves, which was thought to be the perineural space (Rodin et al., 1967; Bockman 
et al., 1994; di Mola&di Sebastiano, 2008). Indeed, a higher proliferative index and decreased 
apoptosis in the perineural space could previously be shown for prostate cancer cells 
invading nerves (Ayala et al., 2004). However, newer studies could demonstrate that 
limiting PCa cells’ presence around nerves to the local physical circumstances may be an 
oversimplification of the utmost frequent NI in Pca (Demir et al., 2010). In particular, the 
development of novel in vitro research tools to study NI in PCa has enabled the discovery of 
a true cancer-nerve affinity as an important biological mechanism in Pca (Zhu et al., 1999; 
Zhu et al., 2002). Especially, we know today that peripheral nerves in the tumor 
microenvironment can serve a source of tumor-trophic factors and cancer-attracting 
molecules (Zhu et al., 1999; Ceyhan et al., 2008; Gil et al., 2010). This “biological cancer-nerve 
affinity” in PCa is today one of the cardinal pathomechanistic concepts in our 
understanding of NI in Pca (Zhu et al., 1999; Ceyhan et al., 2008; Demir et al., 2010; Gil et al., 
2010). 
This increased appreciation of cancer-nerve affinity in PCa was largely possible owing to 
increased efforts to develop novel advanced in vitro models of NI in PCa. These models 
generally employ heterotypic co-cultures of neurons and PCa cells as in of the earliest 
models by Dai et al (Dai et al., 2007). In their study, the investigators co-cultivated the 
human PCa cell line MiaPaCa-2 with neurons from mouse dorsal root ganglia (DRG). In 
accordance with the hypothesized trophic effect of nerves, PCa cells which were co-cultured 
with DRG exhibited stronger growth than non-co-cultured control PCa cells and over-
expressed prosurvival genes like MALT1 and TRAF (Dai et al., 2007). As a frequent 
observation also made by other current models, also PCa cells supported the growth of the 
neurons, as evidenced by their increased neurite growth (Dai et al., 2007). 
This mutual trophic effect gained a further dimension in a recent study by our group where 
we presented another in vitro model which allows a precise spatiotemporal monitoring of 
NI by PCa cells (Ceyhan et al., 2008). As shown in the original article, different PCa cell lines 
were co-cultured together with rat DRG or myenteric plexus (MP) cells in a three-
dimensional (3D) extracellular matrix (ECM)-based migration assay (Ceyhan et al., 2008). 
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The presented assay offers several advantages: First, it initiates from a clear-cut physical 
separation of PCa cells and neurons, as it is the case under in vivo conditions. Therefore, the 
model allows exact monitoring of cell behavior from the very beginning. Second, the model 
includes a pre-defined migration path for PCa cells, i.e. defined ECM-bridges, which allows 
the generation of a chemical gradient for any chemotactic factor (Ceyhan et al., 2008). Using 
this novel assay, we could demonstrate that PCa cells react to the presence of neurons with a 
characteristic morphological alteration including cell flattening, grouping, colony formation 
and spike-like cellular polarization directed towards neurites. Following their targeted 
migration towards neurons, PCa cells established physical contact with neurites along 
which they were guided in their migration (Ceyhan et al., 2008). Similar to the findings by 
Dai et al., we also observed increased neurite growth from DRG neurons towards PCa cells 
when compared to non-co-cultured DRG neurons (Ceyhan et al., 2008). Moreover, the 
presented 3D-migration assay for the first time included a neuronal subtype which 
represents the intrinsic pancreatic neurons, i.e. neurons of the enteric nervous system (ENS). 
The key role of neurotrophins which was initially demonstrated by Zhu et al. for NGF could 
be confirmed by means of this novel assay where we monitored the quantitative alterations 
in the expression of neurotrophins, their receptors and the members of the glial-cell-derived 
neurotrophic factor (GDNF) family (Zhu et al., 1999; Ceyhan et al., 2008). As opposed to 
several members of the GDNF family, the nerve growth factor (NGF) increased 
continuously throughout the migration process of 120 hours (Ceyhan et al., 2008). Certainly, 
this novel 3D migration assays is at the same time a novel tool to investigate the 
contribution of numerous molecular factors from different cellular sources to NI in PCa. A 
very similar model, though without pre-defined paths for chemical gradient generation, has 
been recently reported by Gil et al. where the investigators could demonstrate a potent 
chemotactic effect of GDNF from DRG neurons upon PCa cells (Gil et al., 2010). In a further 
study, our group showed the potent enhancer effect of the neurotrophic factor artemin, a 
member of the GDNF family of neurotrophic factors, upon invasiveness of PCa cells 
(Ceyhan et al., 2006). 
In the presence of an increasing number of studies on the role of neurotrophic factors in NI 
in PCa, there is only a limited of reports on the role of chemokines in NI in PCa (Marchesi et 
al., 2008; Marchesi et al., 2010; Marchesi et al., 2010). In one of the first studies where the 
potential role of chemokines was recognized, Marchesi et al could show that the neural 
immunoreactivity for the receptor of the chemokine fractalkine, i.e. CX3CR1, was 
significantly higher in perineural invasive lesions of PCa (Marchesi et al., 2008). By using 
CX3CR1-overexpressing PCa cells for an in vivo implantation model, they could also 
demonstrate that CX3CR1-overexpressing PCa cells exhibited a more pronounced 
infiltration of peripheral nerves (Marchesi et al., 2008). This study stands out in the literature 
due to the seminal investigation of chemokines in the generation of NI in PCa and pointed 
to the CX3CR1-CX3CL1 as a potential therapeutic target. 
Interestingly, beyond molecules with chemoattractive potential, other nerve-derived 
molecules have also been the focus of recent research on NI in PCa. From these, in a mouse 
perineural invasion and orthotopic transplantation model, the stable knockdown of 
synuclein gamma (synuclein-γ) via by short hairpin RNA significantly reduced the 
incidence of perineural invasion and liver and lymph node metastasis (Hibi et al., 2009). In 
another study where the investigators provided a novel perspective on NI in PCa, Swanson 
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et al. showed that Schwann cells of peripheral nerves express myelin-associated 
glycoprotein (MAG) which can serve as a receptor for the transmembrane mucin MUC1 on 
PCa cells (Swanson et al., 2007). Hence, based on this study, it seems that nerves in PCa 
tissue not only chemo-attract PCa cells but also can undergo direct physical contact, as 
initially observed by Bockman (Swanson et al., 2007; Demir et al., 2010). 
It is conceivable that the presented in vitro models in the literature would enable the 
identification of a gene set which would reflect the differentially upregulated genes in NI in 
PCa. Accordingly, in a recent study, Abiatari et al. aimed at obtaining a transcriptome 
signature of NI in PCa by means of an in vitro / ex vivo model (Abiatari et al., 2009). 
Specifically, they confronted human PCa cell lines with explanted rat vagus nerves and 
quantified the differentially regulated genes in highly versus less nerve-invasive PCa cells 
(Abiatari et al., 2009). Interestingly, the differentially regulated genes which were identified 
by this study were primarily related to cell motility, including kinesin family member 14 
(KIF14) and Rho-GDP dissociation inhibitor beta (ARHGDIbeta), a gene set which they 
could expand in a subsequent by two molecules, i.e., the microtubule-associated protein 
MAPRE2 and the nuclear protein YPEL2 (Abiatari et al., 2009; Abiatari et al., 2009; Abiatari 
et al., 2009). Based on these important observations, the investigators underlined the 
importance of increased PCa cell motility in the generation of NI in PCa as additional 
molecular biological mechanism (Abiatari et al., 2009; Abiatari et al., 2009). 
7.2 In vivo models 
The increasing number of efforts to elucidate the pathomechanism of NI in PCa necessitated 
the creation of in vivo models which better mimic NI in human PCa. The common 
characteristic of these models is that they involve implantation of PCa cells as xenograft 
tumors in one out of several locations, e.g. into the pancreas, under the skin or in the 
proximity of large-diameter peripheral nerves to allow NI by PCa cells. In the first one of 
these models, Eibl et al. aimed at creating a model to simulate the high rates of local 
recurrence and NI after curative resection (Eibl&Reber, 2005). For this purpose, they 
performed complete surgical resection of the tumor at 4, 6, and 8 weeks after orthotopic 
implantation of the PCa cell lines MiaPaCa-2 (undifferentiated) and Capan-2 (well-
differentiated) in nude mice pancreas. Six weeks after tumor implantation, local tumor 
recurrence with extensive retroperitoneal nerve invasion and distant organ metastasis were 
observed in nude mice who had received MiaPaCa-2 cells (Eibl&Reber, 2005). 
Astonishingly, although the investigators achieved a successful simulation of the local 
recurrence and NI  associated with PCa in this murine model, there has since been no 
application of this model to identify further pathomechanistic features of NI in PCa. 
Certainly, the model is probably not suitable to study the initial, early events leading to PCa, 
however, it can possibly be employed to examine the therapeutic potential of different 
agents on NI in PCa in an animal model of PCa. In another model, Koide et al. 
subcutaneously (s.c.) implanted different PCa cell lines with or without human peripheral 
nerves in nonobese diabetes/severe combined immunodeficient mice and analyzed the 
frequency of NI by these different cell lines (Koide et al., 2006). Furthermore, they 
performed an oligonucleotide microarray to obtain the expression profiles of high and low 
perineurally invasive cell lines. Interestingly, only two well-differentiated cell lines (Capan-1 
and Capan-2) demonstrated invasion of mouse s.c. nerves. In these invasive cell lines, they 
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identified over-expression of CD74 in the specifically perineural invasive cells, which they 
confirmed in human PCa tissue specimens (Koide et al., 2006). Despite the implantation of 
PCa cells under skin and not the actual organ of origin (i.e. the pancreas), this model sticks 
out owing to its uncomplicated performance. Still, it has to be underlined that none of these 
in vivo models has so far found widespread application. 
 
Fig. 2. Different sources of molecular actors in neural invasion (NI) in pancreatic cancer 
(PCa). Research from the past 15 years revealed that NI results from a complicated interplay 
of numerous molecular agents derived from different sources, e.g. PCa cells, neurons, 
Schwann cells and stromal cells. Please refer to the main text for the respective references 
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Investigator Model 
characteristics 
Advantages Limitations 
 
In Vitro Models 
 
Dai et al. Matrigel-based 
heterotypic co-
culture 
One of the initial models 
Apt for studying 
expression changes 
No pre-defined chemical 
gradient for chemo-
attractants 
No remark on the initial 
cellular reactions 
Different species of 
confronted cells (murine 
neurons vs. human PCa 
cells) 
Ceyhan et al. ECM-based three-
dimensional 
heterotypic 
migration assay 
Initial physical separation 
of different cells 
Observation of initial 
cellular morphological 
reactions 
“Bridges” to enable 
chemical gradient 
generation 
Usage of myenteric 
neurons 
Different species of 
confronted cells (murine 
neurons vs. human PCa 
cells) 
Abiatari et al. Ex vivo co-culture 
of rat nerves with 
PCa cells 
Easy to perform Confrontation with the 
“large-caliber” vagal nerve 
Different species of 
confronted cells (murine 
neurons vs. human PCa 
cells) 
In Vivo Models 
Eibl et al. Orthotopic PCa cell 
injection followed 
by tumor resection 
(murine) 
Simulation of 
extrapancreatic NI 
Lacking monitoring of 
initial pathophysiological 
events 
 
Gil et al. Tumor injection 
onto murine sciatic 
nerve 
Easy to perform 
Therapeutic monitoring 
by observing degree of 
paralysis 
Confrontation with the 
“large-caliber” sciatic 
nerve 
 
 
Table 1. Experimental models of neural invasion (NI) in pancreatic cancer (PCa). The listed 
in vitro and in vivo models represent complicated heterotypic culture systems and possess 
several differences among each other. Their advantages, however, clearly overweigh their 
limitations. ECM: extracellular matrix. Please refer to the manuscript for the respective 
references. 
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8. Efforts of controlling neural invasion in PCa 
Among all studies in the literature, there are so far two in vivo models of NI in PCa where a 
primarily therapeutic goal was pursued: In the first study, Gil et al. aimed at treating NI by 
means of an attenuated, replication-competent, oncolytic herpes simplex virus which 
inhabits nerves (Gil et al., 2007). After injection of PCa cell lines into the perineurium of the 
sciatic nerve of athymic mice, they monitored limb function for 9 days after injection. 
Excitingly, a single injection of the oncolytic herpes simplex virus 7 days after PCa cell 
injection effectively eradicated NI without compromising physiologic nerve function (Gil et 
al., 2007). The same group utilized this model in a subsequent study for intraoperative 
diagnosis of NI: By using enhanced green fluorescent protein (eGFP)-expressing oncolytic 
herpes virus, they could detect invaded nerves following intrasciatic implantation of PCa 
cell lines via intraoperative fluorescent stereoscopic imaging (Gil et al., 2008). Thereby, they 
proposed a novel tool for enhanced diagnosis and therapy of NI in PCa and for facilitated 
detection of invaded nerves in cases where an extended resection may be considered (Gil et 
al., 2008). In a third study, the group applied PCa cell injection onto mouse sciatic nerves 
and subsequently treated the mice with pyrazolopyrimidine-1, a tyrosine kinase inhibitor 
targeting the RET pathway (Gil et al., 2010). Strikingly, systemic therapy with this agent 
diminished nerve invasion toward the spinal cord and prevented limb paralysis (Gil et al., 
2010). Still, the sensitivity and true effectiveness of their method remains to be confirmed in 
future studies.  
9. Future directions in research on NI in PCa 
Today, research on NI in PCa is in an era of “data collection” and “expansion of 
knowledge”. The increasing number of in vitro and in vivo models, together with the rapidly 
growing scientific interest in NI, create the best possible conditions to learn and discover 
about this peculiar histopathological phenomenon. However, we are convinced that future 
studies should aim at the generation of models with an increasingly therapeutic intention, 
because there is urgent need to employ additional, novel tools to treat PCa. Furthermore, the 
main pathomechanistic hypothesis for the generation of NI, i.e. the neuro-affinity of PCa 
cells, has to be carefully reviewed. It should certainly be considered that PCa cells may not 
be responsible for every aspect of NI, but rather be reacting to the signals coming from the 
nerves. The increasing number of nerve-derived molecules like neurotrophic factors or 
neuronal chemokines which are continuously shown to contribute to NI should serve as a 
motivation to delve deeper into the involvement of neuronal molecules during NI.  
While novel in vitro models of NI in PCa are being steadily developed, the currently 
available in vivo models still exhibit major deficits. In particular, these models lack: 
1. Tumors that directly originate from the pancreas 
2. Histopathological confirmation of the tumor phenotype as ductal adenocarcinoma 
3. The confirmation of the presence of NI even at early stages of tumor development and 
progression  
4. The specific extension of NI towards the extrapancreatic neural plexus 
5. Accompanying neuropathic and desmoplastic alterations  
6. Neuropathic pain sensation 
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Therefore, future in vivo models of NI in PCa should be superior to the current ones in the 
above-mentioned aspects, especially because they should increasingly be employed to 
deduce therapeutic targets and strategies. 
10. Summary and conclusion 
Neural invasion in PCa bears a unique importance in the biology of this disease due its 
impact on patient survival, local tumor reccurence and neuropathic pain sensation. Higher 
interest in NI has paved path for increased research on the biology of NI and accelarated the 
development of numerous experimental models. The discussed in vitro and in vivo models 
which shall help to eludicate the pathomechanisms of NI in PCa may provide novel tools to 
control and to reduce NI in this highly aggressive human malignancy. Considering the 
dismal average prognosis associated with PCa, one may wonder about the actual benefit of 
reducing the specific invasion of nerves in this tumor entity. Here, it should be underlined 
that reduction of NI can be regarded as one of several possibilities to control tumor growth, 
just as adjuvant therapy as an oncological therapy regimen aims at reaching microscopic 
tumor presence and reducing the systemic tumor burden. The control of NI, however, bears 
a further special importance since NI is not only the probably most common mode of spread 
for PCa, but also because nerves represent the most frequent site of local tumor recurrence 
in PCa. Moreover, limitation of NI is likely to have a considerable impact upon the 
neuropathic pain syndrome and thus quality of life of patients with PCa. Therefore, NI may 
find increased attention in the future as an additional therapeutic target for increased 
survival, enhanced postoperative outcome and improved quality of life among all patients 
with this dreadful malignancy. 
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